2-Azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate

Catalog No. :
ACKFXL679
CAS No. :
1818847-38-9
Molecular Formula :
C8H10F3NO3
Molecular Weight :
225.17

IUPAC Name:2-azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate

2-Azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$56.00Login to see priceIn stockInquiry
250mg97%$75.00Login to see priceIn stockInquiry
1g97%$204.00Login to see priceIn stockInquiry
5g97%$632.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate
IUPAC Name2-azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate
MDL No.MFCD29060162
Molecular FormulaC8H10F3NO3
Molecular Weight225.17
SMILESO=C(C1)CC21CNC2.O=C(O)C(F)(F)F
InChI KeyVJFPYVXEDCMULJ-UHFFFAOYSA-N
Synonym1818847-38-9 | 2-azaspiro[3.3]heptan-6-one trifluoroacetate | 2-Azaspiro[3.3]heptan-6-one 2,2,2-trifluoroacetate | 2-azaspiro[3.3]heptan-6-one | 2,2,2-trifluoroacetic acid | MFCD29060162 | PB41423 | AS-53007 | 2-Azaspiro[3.3]heptan-6-onetrifluoroacetate |
CAS No.1818847-38-9
PubChem CID122170263

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACKFXL679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMGAQ307 route compound structure diagram
    ACMGAQ3071181816-12-5 In Stock
  2. Then
  3. ACKFXL679 route product structure diagram
    ACKFXL6791818847-38-9 In Stock
Inquiry

2. ACKFXL679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKJTZ918 route compound structure diagram
    ACKJTZ9181630907-10-6 In Stock
  2. Then
  3. ACKFXL679 route product structure diagram
    ACKFXL6791818847-38-9 In Stock
Inquiry

Comments (0)